HoyleCohen, LLC - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 44 filers reported holding OBALON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HoyleCohen, LLC ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$143,000
-5.3%
204,850
+95.4%
0.02%
-7.4%
Q1 2019$151,000
-30.4%
104,8500.0%0.03%
-38.6%
Q4 2018$217,000
-30.0%
104,850
-8.5%
0.04%
-24.1%
Q3 2018$310,000
+620.9%
114,650
+469.0%
0.06%
+544.4%
Q2 2018$43,000
-37.7%
20,1500.0%0.01%
-35.7%
Q1 2018$69,00020,1500.01%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$24,313,0005.76%
Tamarack Advisers, LP 528,066$5,233,0003.06%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,274,0000.50%
FORMULA GROWTH LTD 108,998$1,080,0000.19%
Moisand Fitzgerald Tamayo, LLC 6,842$268,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,086$1,814,0000.10%
KORNITZER CAPITAL MANAGEMENT INC /KS 422,410$4,186,0000.07%
TIVERTON ASSET MANAGEMENT LLC 130,050$1,289,0000.07%
Bellevue Group AG 45,000$446,0000.05%
Laird Norton Wetherby Wealth Management, LLC 24,038$238,0000.04%
View complete list of OBALON THERAPEUTICS INC shareholders